Galen News – The COVID-19 pandemic brought with it a range of unexpected challenges that affected emerging and established firms in the surgical robotics industry alike, as rapid shifts in capital deployment and procedure demand took place to effectively combat the crisis.
However, Galen Robotics leaned on the strength of its technical basis and the support of dedicated investors to not only survive but thrive in 2020, taking steps to position the Galen Surgical Robotic System for regulatory approval and future commercial success. In this article from the Baltimore Business Journal, CEO Bruce Lichorowic discusses the changes of the past year and outlines the plans for the company going forward.